Neurosterix: Funding, Investors & Team (Nov 2026)
Neurosterix develops pharmaceutical compounds and drug discovery programs focused on treating neuropsychiatric and neurological disorders.
Neurosterix has raised $105M across 1 funding round on record, the most recent a Series B of $105M announced in Nov 2026.
That round is above the $3.8M median round size for Switzerland companies tracked on FundedIQ over the last two years.
Neurosterix Company Profile and Key Stats
Latest funding round on record: Nov 2026.
Neurosterix Funding Rounds
Neurosterix Investors
10 investors are recorded in total; the 5 named above are those the record identifies.
Neurosterix Founders and Leadership Team
Contact details for the Neurosterix team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Neurosterix Funding in Context
Neurosterix's latest round of $105M is above the median round in Switzerland. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Neurosterix in Biopharma and Geneva
Companies Similar to Neurosterix
Vale Biolabs models the human brain using biological data and measures changes in living brain tissue and its…
Laza Medical is a startup focused on producing a high-quality AI-powered robotic imaging solution for…
At CARE, we are transforming the way people can maintain a healthy life for a longer duration. We give…
Atlas Bio is a biotechnology company that develops a predictive foundation AI model of human biology.
Sonexos is an audio engineering company specializing in audio and sound control solutions for automotive and…
Nouscom is a company that develops an immunotherapy platform designed to produce modified viral vector…
SensorX Solutions operates as a manufacturer of IoT sensors.
One interface for every open source model
Food Founders Studio is a venture studio that builds and launches B2B food tech ventures.
Terra Preta is a platform for decentralized biochar production that removes carbon and restores soil health.
Bee People taps into the ingenuity of bees to produce natural health supplements and superfoods.
Prevision Medicine AG is a oncology company that provides cancer therapy, tests living cancer cells, and…
Neurosterix Funding FAQs
What does Neurosterix do?
Neurosterix develops pharmaceutical compounds and drug discovery programs focused on treating neuropsychiatric and neurological disorders.
How much funding has Neurosterix raised?
Neurosterix has raised $105M across 1 round on record. The most recent is a Series B of $105M announced in Nov 2026.
When did Neurosterix last raise funding?
Neurosterix's most recent funding round on record is a Series B of $105M, announced in Nov 2026.
Who has invested in Neurosterix?
Investors on record for Neurosterix include Perceptive Advisors, RTW Investments, Janus Henderson Investors, Affinity Asset Advisors, Google Ventures. FundedIQ records 10 investors in total.
Where is Neurosterix headquartered?
Neurosterix is based in Geneva, Switzerland.
How many employees does Neurosterix have?
Neurosterix is in the 11-50 employee band.
When was Neurosterix founded?
Neurosterix was founded in 2024.
About FundedIQ's Neurosterix Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Neurosterix is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.